TCT-342 Risk and Consequences of Periprocedural Myocardial Infarction Following Off-Label Use of Second Generation Drug-Eluting Stents: Two-Year Follow-up in the TWENTE Trial

Hanim Sen; Ming Kai Lam; Kenneth Tandjung; Mounir W. Basalus; Martin G. Stoel; Gert K. van Houwelingen; F. de Man; Hans W. Louwerenburg; Gerard C. Linssen; Mark B. Nienhuis; Marije M. Löwik; Job van der Palen; Clemens von Birgelen

doi:10.1016/j.jacc.2013.08.1080

TCT-342 Risk and Consequences of Periprocedural Myocardial Infarction Following Off-Label Use of Second Generation Drug-Eluting Stents: Two-Year Follow-up in the TWENTE Trial

Hanim Sen, Ming Kai Lam, Kenneth Tandjung, Mounir W. Basalus, Martin G. Stoel, Gert K. van Houwelingen, F. de Man, Hans W. Louwerenburg, Gerard C. Linssen, Mark B. Nienhuis, Marije M. Löwik, Job van der Palen, Clemens von Birgelen

Faculty of Behavioural, Management and Social Sciences

Research output: Contribution to journal › Article › Academic › peer-review

31 Downloads (Pure)

Original language	English
Pages (from-to)	B109-B109
Journal	Journal of the American College of Cardiology
Volume	62
Issue number	18, Suppl. 1
DOIs	https://doi.org/10.1016/j.jacc.2013.08.1080
Publication status	Published - 2013
Event	25th Annual Scientific Symposium of Transcatheter Cardiovascular Therapeutics, TCT 2013 - San Francisco, United States Duration: 27 Oct 2013 → 1 Nov 2013 Conference number: 25

Keywords

METIS-302487
IR-89482

Access to Document

10.1016/j.jacc.2013.08.1080

Cite this

Sen, H., Lam, M. K., Tandjung, K., Basalus, M. W., Stoel, M. G., van Houwelingen, G. K., de Man, F., Louwerenburg, H. W., Linssen, G. C., Nienhuis, M. B., Löwik, M. M., van der Palen, J., & von Birgelen, C. (2013). TCT-342 Risk and Consequences of Periprocedural Myocardial Infarction Following Off-Label Use of Second Generation Drug-Eluting Stents: Two-Year Follow-up in the TWENTE Trial. Journal of the American College of Cardiology, 62(18, Suppl. 1), B109-B109. https://doi.org/10.1016/j.jacc.2013.08.1080

Sen, Hanim ; Lam, Ming Kai ; Tandjung, Kenneth ; Basalus, Mounir W. ; Stoel, Martin G. ; van Houwelingen, Gert K. ; de Man, F. ; Louwerenburg, Hans W. ; Linssen, Gerard C. ; Nienhuis, Mark B. ; Löwik, Marije M. ; van der Palen, Job ; von Birgelen, Clemens. / TCT-342 Risk and Consequences of Periprocedural Myocardial Infarction Following Off-Label Use of Second Generation Drug-Eluting Stents : Two-Year Follow-up in the TWENTE Trial. In: Journal of the American College of Cardiology. 2013 ; Vol. 62, No. 18, Suppl. 1. pp. B109-B109.

@article{5f0fd1b2da224391ae1e4a5ea39eeda7,

title = "TCT-342 Risk and Consequences of Periprocedural Myocardial Infarction Following Off-Label Use of Second Generation Drug-Eluting Stents: Two-Year Follow-up in the TWENTE Trial",

keywords = "METIS-302487, IR-89482",

author = "Hanim Sen and Lam, {Ming Kai} and Kenneth Tandjung and Basalus, {Mounir W.} and Stoel, {Martin G.} and {van Houwelingen}, {Gert K.} and {de Man}, F. and Louwerenburg, {Hans W.} and Linssen, {Gerard C.} and Nienhuis, {Mark B.} and L{\"o}wik, {Marije M.} and {van der Palen}, Job and {von Birgelen}, Clemens",

note = "Special issue: Twenty-Fifth Annual Symposium Transcatheter Cardiovascular Therapeutics (TCT)–Abstracts ; 25th Annual Scientific Symposium of Transcatheter Cardiovascular Therapeutics, TCT 2013, TCT 2013 ; Conference date: 27-10-2013 Through 01-11-2013",

year = "2013",

doi = "10.1016/j.jacc.2013.08.1080",

language = "English",

volume = "62",

pages = "B109--B109",

journal = "Journal of the American College of Cardiology",

issn = "0735-1097",

publisher = "Elsevier",

number = "18, Suppl. 1",

}

Sen, H, Lam, MK, Tandjung, K, Basalus, MW, Stoel, MG, van Houwelingen, GK, de Man, F, Louwerenburg, HW, Linssen, GC, Nienhuis, MB, Löwik, MM, van der Palen, J & von Birgelen, C 2013, 'TCT-342 Risk and Consequences of Periprocedural Myocardial Infarction Following Off-Label Use of Second Generation Drug-Eluting Stents: Two-Year Follow-up in the TWENTE Trial', Journal of the American College of Cardiology, vol. 62, no. 18, Suppl. 1, pp. B109-B109. https://doi.org/10.1016/j.jacc.2013.08.1080

TCT-342 Risk and Consequences of Periprocedural Myocardial Infarction Following Off-Label Use of Second Generation Drug-Eluting Stents : Two-Year Follow-up in the TWENTE Trial. / Sen, Hanim; Lam, Ming Kai; Tandjung, Kenneth; Basalus, Mounir W.; Stoel, Martin G.; van Houwelingen, Gert K.; de Man, F.; Louwerenburg, Hans W.; Linssen, Gerard C.; Nienhuis, Mark B.; Löwik, Marije M.; van der Palen, Job ; von Birgelen, Clemens.

In: Journal of the American College of Cardiology, Vol. 62, No. 18, Suppl. 1, 2013, p. B109-B109.

Research output: Contribution to journal › Article › Academic › peer-review

TY - JOUR

T1 - TCT-342 Risk and Consequences of Periprocedural Myocardial Infarction Following Off-Label Use of Second Generation Drug-Eluting Stents

T2 - 25th Annual Scientific Symposium of Transcatheter Cardiovascular Therapeutics, TCT 2013

AU - Sen, Hanim

AU - Lam, Ming Kai

AU - Tandjung, Kenneth

AU - Basalus, Mounir W.

AU - Stoel, Martin G.

AU - van Houwelingen, Gert K.

AU - de Man, F.

AU - Louwerenburg, Hans W.

AU - Linssen, Gerard C.

AU - Nienhuis, Mark B.

AU - Löwik, Marije M.

AU - van der Palen, Job

AU - von Birgelen, Clemens

N1 - Conference code: 25

PY - 2013

Y1 - 2013

KW - METIS-302487

KW - IR-89482

U2 - 10.1016/j.jacc.2013.08.1080

DO - 10.1016/j.jacc.2013.08.1080

M3 - Article

VL - 62

SP - B109-B109

JO - Journal of the American College of Cardiology

JF - Journal of the American College of Cardiology

SN - 0735-1097

IS - 18, Suppl. 1

Y2 - 27 October 2013 through 1 November 2013

ER -

Sen H, Lam MK, Tandjung K, Basalus MW, Stoel MG, van Houwelingen GK et al. TCT-342 Risk and Consequences of Periprocedural Myocardial Infarction Following Off-Label Use of Second Generation Drug-Eluting Stents: Two-Year Follow-up in the TWENTE Trial. Journal of the American College of Cardiology. 2013;62(18, Suppl. 1):B109-B109. https://doi.org/10.1016/j.jacc.2013.08.1080